垂体后叶素治疗肺结核咯血105例临床观察  

作　　者：翟洁卿[1] 殷思纯[1] 何松美[1] 

机构地区：[1]东莞市人民医院感染科,523008

出　　处：《当代医学》2012年第17期78-79,共2页Contemporary Medicine

摘　　要：目的探讨垂体后叶素治疗肺结核咯血的临床治疗效果及其可行性。方法对收治的105例肺结核咯血患者采用垂体后叶素治疗,观察其治疗效果及不良反应发生情况。结果经垂体后叶素治疗后,显效45例,有效54例,无效6例,总有效率94.29%;所有患者均无明显不良反应。结论垂体后叶素治疗肺结核咯血操作方便、疗效好,安全可靠、费用低,无严重不良反应,值得临床广泛应用。Objective To investigate the treatment effect and its feasibility of after the pituitary gland YeSu cure for tuberculosis haemoptysis.Methods In our 105 cases were tuberculosis patients with pituitary YeSu after the haemoptysis treatment,observe the treatment effect,and the adverse reaction.Results After the YeSu pituitary treatment,powerfully 45 cases,effective 54 cases effectiveness and 6 cases,the total effective rate of 94.29%;All of the patients have no obvious adverse reactions.Conclusion The pituitrin treats pulmonary tuberculosis hemoptysis to have the ease of operation,the curative effect is good,safe reliable,the expense is low,not serious responded not good and so on the merits,are worth the clinical widespread application.

关 键 词：垂体后叶素 肺结核咯血 治疗 临床观察 

分 类 号：R521[医药卫生—内科学]